Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Plexus Corp's positive outlook is underpinned by a solid performance in its Health Care Life Sciences segment, which reported a revenue increase of 5% year-over-year for the full year, reaching $1.629 billion, with expectations of continued growth in the upcoming quarter. The Aerospace & Defense segment is anticipated to experience mid-single-digit growth quarter-over-quarter, driven by program ramp-ups and demand in both commercial air and defense sectors, aligning with the company's revenue growth goal of 9-12%. Furthermore, excluding the impact of restructuring charges, Plexus's earnings are projected to grow at nearly double the pace of revenue, indicating strong operational leverage as the company's strategic initiatives unfold.

Bears say

Plexus Corp has experienced a decline in gross margin from 10.1% to 9.9% in FQ4, indicating pressure on profitability, while revenue from the Aerospace & Defense segment fell by 6% both quarter-over-quarter and year-over-year. Furthermore, the company anticipates a decrease in Industrial revenues in the upcoming quarter, reflecting seasonal fluctuations and moderating demand, despite expectations for modest growth in fiscal year 2026. These financial challenges are compounded by broader economic concerns, such as signs of a global slowdown and potential disruptions in manufacturing, which add to Plexus's company-specific risks and competitive pressures.

Plexus (PLXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 4 analysts, Plexus (PLXS) has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $157.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $157.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.